Compound Detail
CHEMBL396778
SAFINAMIDE 💊 Approved Drug
Enter ChEMBL ID:
Free Research Context
This compound will appear in recent viewed items on the research home for this browser.
Research home
View demo workspace
💊 Approved Drug
Basic Information
| ChEMBL ID | CHEMBL396778 |
| Name | SAFINAMIDE |
| Phase | Approved |
| Structure Type | MOL |
| InChI Key | NEMGRZFTLSKBAP-LBPRGKRZSA-N |
| Therapeutic | ✓ Yes |
5
Targets
86
Activities
4
Assay Types
30
PK Parameters
20
Publications
5
Known Names
4
Indications
1
Mechanisms
Molecular Properties
302.4
MW (Da)
2.37
ALogP
3
HBA
2
HBD
64.3
PSA (Ų)
0.83
QED
0
Ro5 Violations
7
Rot. Bonds
Drug Information
| Molecule Type | Small molecule |
| First Approval | 2015 |
| Availability | Prescription |
| Chirality | Single Enantiomer |
Mechanism of Action
| Mechanism | Action Type | Target | Direct | Efficacy |
|---|---|---|---|---|
| Monoamine oxidase B inhibitor | INHIBITOR | Amine oxidase [flavin-containing] B | ✓ | ✓ |
Indications
Parkinson Disease Multiple System Atrophy Kidney Diseases Liver Diseases
ATC Classification
N04BD03
safinamide
Level 1: NERVOUS SYSTEM
Level 2: ANTI-PARKINSON DRUGS
Activity Summary
IC50 78 meas. best 8.29
Ki 6 meas. best 8.64
EC50 1 meas. best 4.82
Kd 1 meas. best 6.73
Target Activity Profile
| Target | Type | Best pChEMBL | Mean pChEMBL | Best (nM) | # Data |
|---|---|---|---|---|---|
| Amine oxidase [flavin-containing] B CHEMBL2039 | Ki | 8.64 | 7.936 | 2.3 | 5 |
| Amine oxidase [flavin-containing] B CHEMBL2039 | IC50 | 8.29 | 7.5105 | 5.1 | 57 |
| Amine oxidase [flavin-containing] B CHEMBL2993 | IC50 | 7.75 | 7.1567 | 18.0 | 6 |
| Amine oxidase [flavin-containing] A CHEMBL1951 | IC50 | 7.52 | 4.69 | 30.0 | 7 |
| Amine oxidase [flavin-containing] B CHEMBL2039 | Kd | 6.73 | 6.73 | 187.2 | 1 |
| Amine oxidase [flavin-containing] A CHEMBL3358 | IC50 | 5.55 | 5.55 | 2800.0 | 1 |
| Amine oxidase [flavin-containing] B CHEMBL2039 | EC50 | 4.82 | 4.82 | 15000.0 | 1 |
| Sodium channel protein type 9 subunit alpha CHEMBL4296 | IC50 | 4.48 | 4.24 | 33000.0 | 2 |
Pharmacokinetic Data
| Parameter | Value | Units | Species |
|---|---|---|---|
| AUC | 253.0 | ng.hr.mL-1 | Rattus norvegicus |
| AUC | 795.0 | ng.hr.mL-1 | Rattus norvegicus |
| AUC | 2120.0 | ng.hr.mL-1 | Macaca fascicularis |
| AUC | 13100.0 | ng.hr.mL-1 | Macaca fascicularis |
| AUC | 233.0 | ng.hr.mL-1 | Rattus norvegicus |
| AUC | 536.0 | ng.hr.mL-1 | Rattus norvegicus |
| AUC | 930.0 | ng.hr.mL-1 | Mus musculus |
| AUC | 3050.0 | ng.hr.mL-1 | Mus musculus |
| CL | 65.5 | mL.min-1.kg-1 | Rattus norvegicus |
| CL | 34.6 | mL.min-1.kg-1 | Macaca fascicularis |
| CL | 70.6 | mL.min-1.kg-1 | Rattus norvegicus |
| CL | 34.7 | mL.min-1.kg-1 | Mus musculus |
| CL | 2.8 | mL.min-1.kg-1 | Homo sapiens |
| CL | 43.2 | mL.min-1.kg-1 | Mus musculus |
| CL | 38.3 | mL.min-1.kg-1 | Rattus norvegicus |
| CL | 43.2 | mL.min-1.kg-1 | Canis lupus familiaris |
| Cmax | 932.69 | nM | Rattus norvegicus |
| Cmax | 1399.04 | nM | Rattus norvegicus |
| Cmax | 3572.02 | nM | Macaca fascicularis |
| Cmax | 6515.63 | nM | Macaca fascicularis |
| Cmax | 807.01 | nM | Rattus norvegicus |
| Cmax | 489.5 | nM | Rattus norvegicus |
| Cmax | 1418.89 | nM | Mus musculus |
| Cmax | 2497.11 | nM | Mus musculus |
| F | 63.2 | % | Rattus norvegicus |
| F | 110.7 | % | Macaca fascicularis |
| F | 48.5 | % | Rattus norvegicus |
| F | 128.8 | % | Mus musculus |
| T1/2 | 1.03 | hr | Rattus norvegicus |
| T1/2 | 1.02 | hr | Rattus norvegicus |
Activity Data Samples
Top measurements by pChEMBL value
Literature References
| PubMed | DOI | Target Context | # Activities |
|---|---|---|---|
| 37001389 | 10.1016/j.ejmech.2023.115308 | ADMET | 35 |
| 34871839 | 10.1016/j.ejmech.2021.114025 | ADMET | 19 |
| 25600407 | 10.1016/j.bmc.2014.12.063 | Amine oxidase [flavin-containing] B | 7 |
| 20394379 | 10.1021/jm100185c | Mus musculus | 6 |
| 36716641 | 10.1016/j.ejmech.2023.115142 | Mus musculus | 5 |
| 24955776 | 10.1021/jm500729a | Amine oxidase [flavin-containing] B | 5 |
| 38894921 | 10.1021/acsmedchemlett.3c00532 | Amine oxidase [flavin-containing] B | 4 |
| 38838545 | 10.1016/j.ejmech.2024.116566 | Amine oxidase [flavin-containing] B | 4 |
| 31265934 | 10.1016/j.ejmech.2019.06.041 | Amine oxidase [flavin-containing] B | 4 |
| 23631427 | 10.1021/jm400336x | Amine oxidase [flavin-containing] B | 3 |
| 35195417 | 10.1021/acs.jmedchem.1c01784 | Amine oxidase [flavin-containing] B | 3 |
| 38838545 | 10.1016/j.ejmech.2024.116566 | Mus musculus | 3 |
| 36716641 | 10.1016/j.ejmech.2023.115142 | Amine oxidase [flavin-containing] B | 3 |
| 27244485 | 10.1021/acs.jmedchem.6b00527 | Amine oxidase [flavin-containing] B | 3 |
| - | 10.6019/CHEMBL4808148 | Histone deacetylase 6 | 3 |
| 30404719 | 10.1016/j.bmcl.2018.10.048 | Amine oxidase [flavin-containing] B | 3 |
| 35397400 | 10.1016/j.ejmech.2022.114329 | Amine oxidase [flavin-containing] B | 3 |
| 30522087 | 10.1016/j.ejmech.2018.11.009 | Amine oxidase [flavin-containing] B | 2 |
| - | 10.6019/CHEMBL4495565 | SARS-CoV-2 | 2 |
| 30522087 | 10.1016/j.ejmech.2018.11.009 | No relevant target | 2 |
Data from ChEMBL 36 via Core Engine